Abstract
This chapter describes a two-dimensional “monolayer” system for differentiating human pluripotent stem cells (PSCs) into “primitive” hematopoietic progenitor cells (HPCs) resembling those produced in vivo by the early embryonic yolk sac. This experimental system utilizes defined conditions without serum or feeder cells. Cytokines are added sequentially to stimulate the formation of mesoderm and its subsequent patterning to hematopoietic progenitors. The HPCs produced by this protocol have multi-lineage potential (erythroid, megakaryocyte, and myeloid) and can be isolated as a homogeneous population for use in standard hematopoietic studies including liquid expansion to mature lineages and colony assays. In addition, the HPCs can be cryopreserved for distribution or analysis at later times. The HPCs generated by this protocol have been used successfully to better define intrinsic variation in hematopoietic potential between different PSC lines and to model human hematopoietic diseases using patient-derived induced pluripotent stem cells.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Yoshida Y, Yamanaka S (2010) Recent stem cell advances: induced pluripotent stem cells for disease modeling and stem cell-based regeneration. Circulation 122:80–87
Murry CE, Keller G (2008) Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell 132:661–680
Orkin SH, Zon LI (2008) Hematopoiesis: an evolving paradigm for stem cell biology. Cell 132:631–644
Migliaccio G, Migliaccio AR et al (1986) Human embryonic hemopoiesis. Kinetics of progenitors and precursors underlying the yolk sac—liver transition. J Clin Invest 78:51–60
Tavian M, Peault B (2005) Embryonic development of the human hematopoietic system. Int J Dev Biol 49:243–250
McGrath K, Palis J (2008) Ontogeny of erythropoiesis in the mammalian embryo. Curr Top Dev Biol 82:1–22
McGrath KE, Frame JM et al (2011) A transient definitive erythroid lineage with unique regulation of the beta-globin locus in the mammalian embryo. Blood 117:4600–4608
Schechter AN (2008) Hemoglobin research and the origins of molecular medicine. Blood 112:3927–3938
Dzierzak E, Speck NA (2008) Of lineage and legacy: the development of mammalian hematopoietic stem cells. Nat Immunol 9:129–136
Choi KD, Vodyanik MA et al (2012) Identification of the hemogenic endothelial progenitor and its direct precursor in human pluripotent stem cell differentiation cultures. Cell Rep 2:553–567
Kennedy M, Awong G et al (2012) T lymphocyte potential marks the emergence of definitive hematopoietic progenitors in human pluripotent stem cell differentiation cultures. Cell Rep 2:1722–1735
Slukvin II (2013) Hematopoietic specification from human pluripotent stem cells: current advances and challenges toward de novo generation of hematopoietic stem cells. Blood 122:4035–4046
Kaufman DS, Hanson ET et al (2001) Hematopoietic colony-forming cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A 98:10716–10721
Vodyanik MA, Bork JA et al (2005) Human embryonic stem cell-derived CD34+ cells: efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential. Blood 105:617–626
Takayama N, Nishikii H et al (2008) Generation of functional platelets from human embryonic stem cells in vitro via ES-sacs, VEGF-promoted structures that concentrate hematopoietic progenitors. Blood 111:5298–5306
Zambidis ET, Peault B et al (2005) Hematopoietic differentiation of human embryonic stem cells progresses through sequential hematoendothelial, primitive, and definitive stages resembling human yolk sac development. Blood 106:860–870
Ng ES, Davis RP et al (2005) Forced aggregation of defined numbers of human embryonic stem cells into embryoid bodies fosters robust, reproducible hematopoietic differentiation. Blood 106:1601–1603
Kennedy M, D'Souza SL et al (2007) Development of the hemangioblast defines the onset of hematopoiesis in human ES cell differentiation cultures. Blood 109:2679–2687
Mills JA, Wang K et al (2013) Clonal genetic and hematopoietic heterogeneity among human-induced pluripotent stem cell lines. Blood 122:2047–2051
Chou ST, Byrska-Bishop M et al (2012) Trisomy 21-associated defects in human primitive hematopoiesis revealed through induced pluripotent stem cells. Proc Natl Acad Sci U S A 109:17573–17578
Gandre-Babbe S, Paluru P et al (2013) Patient-derived induced pluripotent stem cells recapitulate hematopoietic abnormalities of juvenile myelomonocytic leukemia. Blood 121:4925–4929
Garcon L, Ge J et al (2013) Ribosomal and hematopoietic defects in induced pluripotent stem cells derived from Diamond Blackfan anemia patients. Blood 122:912–921
Gadue P, Huber TL et al (2006) Wnt and TGF-beta signaling are required for the induction of an in vitro model of primitive streak formation using embryonic stem cells. Proc Natl Acad Sci U S A 103:16806–16811
Watanabe K, Ueno M et al (2007) A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat Biotechnol 25:681–686
Mikkola HK, Fujiwara Y et al (2003) Expression of CD41 marks the initiation of definitive hematopoiesis in the mouse embryo. Blood 101:508–516
Klimchenko O, Mori M et al (2009) A common bipotent progenitor generates the erythroid and megakaryocyte lineages in embryonic stem cell-derived primitive hematopoiesis. Blood 114:1506–1517
Vodyanik MA, Thomson JA et al (2006) Leukosialin (CD43) defines hematopoietic progenitors in human embryonic stem cell differentiation cultures. Blood 108:2095–2105
Choi KD, Vodyanik MA et al (2009) Generation of mature human myelomonocytic cells through expansion and differentiation of pluripotent stem cell-derived lin-CD34 + CD43 + CD45+ progenitors. J Clin Invest 119:2818–2829
Choi KD, Yu J et al (2009) Hematopoietic and endothelial differentiation of human induced pluripotent stem cells. Stem Cells 27:559–567
Maclean GA, Menne TF et al (2012) Altered hematopoiesis in trisomy 21 as revealed through in vitro differentiation of isogenic human pluripotent cells. Proc Natl Acad Sci U S A 109:17567–17572
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this protocol
Cite this protocol
Mills, J.A., Paluru, P., Weiss, M.J., Gadue, P., French, D.L. (2014). Hematopoietic Differentiation of Pluripotent Stem Cells in Culture. In: Bunting, K., Qu, CK. (eds) Hematopoietic Stem Cell Protocols. Methods in Molecular Biology, vol 1185. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-1133-2_12
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1133-2_12
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-1132-5
Online ISBN: 978-1-4939-1133-2
eBook Packages: Springer Protocols